extensive studies of all aspects of their immune system. Among other phenomena, it was found that stimulation of normal NZB lymphocytes in vitro with H-2-identical BALB/c or DBA/2 lymphocytes readily induced cytotoxic T cell responses (2, 3). We (4) and others (5) have shown that this primary in vitro response is directed against antigens of the Tla region, where NZB mice differ from other H-2 d strains (6). In the course of that study, we observed that when primed NZB lymphocytes were restimulated with BALB/c cells in vitro, they became cytotoxic to target cells of all strains tested, with the exception of NZB. Here we analyze the specificity of this secondary response. Whereas the response itself is a normal T cell response to an antigen present in nearly all other strains but missing in NZB, the antigen is unusual.
The percent specific 5aCr-release was calculated from the geometric means (8) of triplicate determinations as:
(mean experimental release -mean spontaneous release)
x 100.
(mean maximal release -mean spontaneous release)
The average SD of 2,800 sets of triplicates amounted to 8.2% of the respective means.
Cold target inhibition was carried out in round-bottomed microtiter plates; each well contained 1 X 104 51Gr-labeled target cells, 3 X 106 cold target cells, and effector cells generated from 3 x I0 s responder cells (8) . Maximal inhibition is to be expected with the specific target as cold target inhibitor; minimal inhibition should be observed with the responder itself as cold inhibitor. The degrees of lysis were always evaluated in terms of these two controls. With the number of combinations to be assayed, it was not feasible to test killers and inhibitors in several ratios. Thus, depending on the efficiency of the killers, revealed only by the assay, the reduction of lysis with a fixed number of effective inhibitors could therefore be complete or intermediate (cf. the two anti-H-2 d killers in Fig. 5 ) or occasionally barely significant (of. the anti-H-2 k killers in Fig. 4 ). All experiments have been done at least twice, giving the same typing results.
T Cell Enrichment and Depletion. Spleen (and occasionally lymph node) cells were passed through nylon-wool columns (9) or columns of glass beads coated with mouse immunoglobulin (Ig) and rabbit anti-mouse Ig (10) . The percentage of Ig-positive cells in the effluent was determined by indirect immunofluoreseent staining (4) . T cells were removed by treatment with a monoclonal anti-Thy-l.2 antibody, F7D5 (a generous gift from Dr. P. Lake, University College, London), and complement (G0. Spleen cells or cultured effector cells were incubated at 1 × 107/ml of a 1:1,000 dilution of ascitic fluid for 30 min on ice, washed once, and then incubated for 45 min at 37°G with the same volume of a 1:10 dilution of rabbit C', selected for low natural cytotoxicity on BALB/c thymocytes. After two washings, responder and effector cells were assayed on the basis of the number of initial responder cells treated.
Results
Pn'ma~y and Secondary NZB anti-BALB/c Responses. NZB mice differ from H-2-identical BALB/c and DBA/2 mice in the Tla region by the serologically defined TL and Qa-1 antigens (6) and by Qed-1, a target antigen for unrestricted T cell killing (4). Because Qed-1 stimulates primary cytotoxic responses in vitro in several strain combinations (4), it is likely to be involved in a primary NZB anti-BALB/c response. Fig. 1) were not lysed, confirming that the response is specific for Qed-1 (4, 5) . When the NZB lymphocytes were primed in vivo with BALB/c and then restimulated in vitro, a strong cytotoxic response was seen on all target cells tested, irrespective of their H-2 or Qed-1 type (Fig. 1) . The response was specific because NZB target cells were not killed. It required restimulation with BALB/c because primed NZB responder cells cultured with syngeneic irradiated cells displayed no cytotoxic activity.
With cold target inhibition of the killing of appropriately selected radiolabeled target cells, it is possible to distinguish the specificities involved in complex cytotoxic responses (4, 8) . last specificity. Every target cell that was killed in Fig. 1 inhibits the lysis of B6. Tla a, showing that they all share the antigen detected here. We shall call this antigen Mta. Strain Distribution of Mta. Table I lists the strains that have been typed for Mta, usually by cold target inhibition of lysis but occasionally, where Qed-l b-specific or H2d-restricted lysis could be excluded, by direct lysis. The only Mta-non-NZB strain found to date is the non-inbred NMRI strain. The 26 strains found positive for Mta included 9 different H-2 haplotypes and about 14 different non-H-2 backgrounds, of which at least 8 can be considered unrelated (11) . The antigen was found in mice from six different sources, and was detected in experiments performed in Basel as well as in Philadelphia, making it unlikely that the antigen is the result of an infection in the holding facilities which spread to all incoming mice.
Mta was found even among NZB mice. Cold target inhibition tests showed that the NZB substrain maintained at the Institut f'tir Biologiseh-Medizinische Forschung, Fiillinsdorf, Switzerland (provisionally designated NZB/FiiI1) was Mta +. This line has been developed from breeding pairs provided in 1978 by Dr. M. Potter, National Cancer Institute, Bethesda, Md. Dr. Potter's line (NZB/BIPt) originated around 1968 from breeders obtained from Dr. L. W. Law, National Cancer Institute. Table III shows that although primed NZB/CrBom anti-BALB/c effector cells do not react with target ceils from NZB mice obtained from The Jackson Laboratory, Bar Harbor, Maine or from the Institute for Cancer Research, they kill both NZB/Fiill and NZB/ BIPt target cells.
By immunizing NZB/CrBom mice with spleen cells from NZB/Fiill mice, it is possible to generate Mta-specifie CTL in the absence of a response against Qed-1 b, making direct Mta typing easier (Table III) . However, some part of the response must be directed against minor histoeompatibility antigens (presumably H-2 d restricted), because the lysis of NZB/Fiill target cells is not inhibited by excess BALB/c targets that share Mta (data not shown). As expected, immunization of NZB/Fiill mice with BALB/c cells induces a Qed-lb-specific response (C57BL/6 vs. B6.Tla a targets in Table III ) and a response against minor histocompatibility antigens (lysis of NZB/ BINJ targets), but no response against Mta (failure to lyse B6. Tla" and C58/J). U Equivalents based on number of cells initially treated. ¶ --, not done. Table III suggest that NZB/Fiill differs little, if at all, from NZB/BIPt. Cold target cells from both of these substrains have been shown to inhibit Mta-specific cytotoxicity, although on occasion less efficiently than cells from other strains (an example occurs in Table V) . Nature of the Responding CelL The cell that responds to Mta is a T cell. It passes through nylon wool or rabbit anti-mouse Ig columns and is killed by monoclonal anti-Thy-l.2 antibodies and C', both before and after culture (Table IV) . It requires priming, because normal NZB ceils mixed with T-depleted primed NZB cells and stimulated with BALB/c could respond to Qed-1 b, but not to Mta.
Immunization of NZB/FiJll with NZB/Bom generates an H-2d-restricted response against minor histocompatibility antigens (lysis of BALB/c, not BALB.B [data not shown]; the lysis of C58/J was not reproduced in four other experiments). The data in

Distribution of Mta on Lymphoid Cells. In all the above experiments, LPS-stimulated
spleen cells were used as targets. As shown in Fig. 3 , similar responses were obtained on phytohemagglutinin (PHA)-or ConA-stimulated lymphoblasts. Mta could also be demonstrated on fresh, normal spleen cells, T cells as well as B cells. The lower plateau levels of lysis are characteristic of normal spleen cells as targets, whatever the effector cell specificity (4). Mta was also detectable by direct lysis on a number of cloned C57BL/6 T helper cell lines (described in [12] ).
Some frequently used tumor target cell lines have also been typed for Mta by cold target inhibition (Table V) and direct lysis (data not shown). All were strongly positive, even those with very low levels of H-2 antigens (K. Fischer Lindahl. Unpublished observations.).
Genetics of Mta.
To determine whether Mta, like most other target antigens for unrestricted T cell killing, was encoded by genes linked to the H-2 complex, we typed the existing recombinant inbred (RI) strains derived from crosses of NZB/Icr (Mta-, H-2 a) and C58/J (Mta ÷, H-2k). The results show that five strains were Mta-and eight strains Mta ÷ (Fig. 4) . The H-2 typing, done by cold target inhibition of killing in the same experiments as the Mta typing, agrees with previous results (7), except for NXS-9. The previously reported subline of this strain is extinct, and the surviving subline is H-2 k. The distribution of Mta among the RI lines showed no association with H-2 (among the positive mice, four were H-2 k and four were H-2a; among the negatives, three were H-2 k and two were H-2 a) or with any other marker for which these mice have been typed (7). 2 On the other hand, the strain distribution pattern of Mta is perfectly correlated with the construction of the original matings from which the strains were derived. (---) ; the latter effector cells gave 53% specific 51Or-release fi'om C57BL/6 LPS blasts at 30 initial responders/target cell. X 8¢~)F12 X (N2 X 8d) Fxd, strains RI 6 and 9 from (N X 8) X (8 x N), strains RI 13 and 15 from (8 X N) X (8 X N), and strains RI 16-20 from (8 X N) X (N X 8); i.e., the maternal line of descent the Mta-strains is derived from NZB, whereas the maternal line of descent of the Mta + strains is derived from C58. These results forcefully suggest a maternal effect on the expression of Mta, and this was tested on reciprocal F1 hybrids between Mta-(NZB) and Mta + (BALB/c and C58/J) strains (Fig. 5) . Although the cells from F1 hybrids of reciprocal crosses inhibited H-2d-specific cytotoxicity equally well, only those derived from an Mta + mother inhibited Mtaspecific lysis. F1 hybrids derived from a negative mother were negative. The female reciprocal F1 hybrids between NZB and BALB/c are particularly informative, because these mice should be genotypically identical. We also included cold target cells from very old (>2 yr) NZB/Icr mice in these experiments. Plainly, Mta is not acquired with age (Fig. 5) .
Backcrossing Mta + (A.CA9 X NZBd)Fx hybrids to NZB females produced Mtaoffspring, whereas backcrossing to NZB males yielded Mta + offspring (Fig. 6) . The results for all backcross animals are summarized in Table VI . The probability of getting the observed or a more extreme distribution of the H-2 ~ haplotype is 0.247 (Fisher's exact test); the probability of getting the observed distribution of Mta by chance alone is 1.9 X 10 -7.
Discussion
Our experiments serve to define a new target antigen for unrestricted T cell killing. The antigen, termed Mta (for maternally transmitted antigen), is carried by most mouse strains tested except for some NZB substrains and non-inbred NMRI mice. The antigen is displayed by all lymphoid target cells and a number of tumor cell lines. Mta did not segregate with H-2 or any other marker; rather, the rule, to which we found no exception, is that Mta + females bear positive offspring whatever the phenotype of the male may be, and Mta-mothers bear negative offspring. The phenotypes of NX8 recombinant inbred strains (Fig. 4) and of backcross mice ( Fig. 6 and Table VI ) make sex-linkage of Mta unlikely, and the typing of reciprocal F1 hybrids (Fig. 5) rules it out. Two alternatives remain. Perhaps all mice have the genetic information to produce Mta, and there is an epigenetic transmission from negative mothers of a principle that prevents expression of Mta for the lifetime of their offspring. It is not easy to envisage such a mechanism and, even though our experiments to date do not rule it out, we favor the alternative, a maternally transmitted genetic element coding for the antigen (Mta).
Such a maternally transmitted antigen might be passed on via the egg, through the placenta, or in the milk; it is likely to be a virus. Milk-transmitted mammary tumor virus is a well-established precedent (13); moreover, it has been reported to give rise to unrestricted T cell killing (14) . Foster-nursing of hysterectomy-derived mice by NZB/Icr or BALB/c mothers gave no evidence that Mta is milk-transmitted (K.
Fischer Lindahl, M. Bocchieri, and R. Riblet. Manuscript in preparation.), and (Fig. 5) ; the Mta + NZB/BIPt substrain and its derivative NZB/Fiill differ from other NZB substrains by additional antigens, suggesting a genetic contamination of the line (Table II1) strain is prone to various lymphoproliferative disorders (M. Potter. Personal communication.). Finally, a study of reciprocal FI hybrids between NZB and DBA/2 showed no difference in their ability to produce autoantibodies (16) . Summary A new target antigen for unrestricted killing was defined by NZB T lymphocytes which were immunized and restimulated with H-2-identical BALB/c spleen cells.
